Epilepsy Clinical Trials in New York

Showing 101-120 of 141 trials

Study to Evaluate Serum Free Thyroxine (FT4) and Free Triiodothyronine (FT3) Measurements for Subjects Treated With Eslicarbazeine Acetate (ESL)

NCT02491073

The purpose of this research study is to determine if the blood tests used to measure free thyroid hormone levels are affected by a drug called eslicarbazepine acetate. To determine if eslicarbazepine acetate interferes with these blood tests, blood samples will be analysed so that researchers can compare different types of lab tests that measure these thyroid hormones. Half of the people who participate in this study will already be taking eslicarbazepine acetate either as a study drug or as a prescription (Part 1) and the other half will be people who do not take eslicarbazepine acetate (Part 2).

Epilepsy

Sumitomo Pharma America, Inc.71 participantsStarted Sep 2015

Sun City, Arizona, United States • Boise, Idaho, United States • Lexington, Kentucky, United States +4 more locations

COMPLETEDPhase 3< 1 mile

Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy

NCT01128959

The purpose of this study is to assess the safety and tolerability of intravenous (IV) carbamazepine (CBZ) administered as multiple 15 minute infusions and a single 5 minute infusion to adult patients with epilepsy on stable higher doses of oral CBZ.

Epilepsy

Lundbeck LLC108 participantsStarted Jun 2010

Phoenix, Arizona, United States • Little Rock, Arkansas, United States • Torrance, California, United States +26 more locations

Study to Evaluate Serum Free Thyroxine (FT4) and Free Triiodothyronine (FT3) Measurements for Subjects Treated With Eslicarbazeine Acetate (ESL)

Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy

Epilepsy Trials in Other Cities

Depression and Health Outcomes in Refractory Epilepsy

Neuropsychological Evaluation of Psychiatric and Neurological Patients

Pre-oxygenation and Measures of Gas Exchanges During Seizures in the Epilepsy Monitoring Unit

Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Primary Generalized Tonic-Clonic Seizures (PGTC) Seizures

Retigabine (Adjunctive Therapy) Efficacy and Safety Study for Partial Onset Refractory Seizures in Epilepsy

Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures

Patients With Epilepsy Taking LAMICTAL Immediate-Release Who Switch To Extended-Release Formulation And Vice Versa

A Study of the Structure and Function of the Retina in Adult Patients With Refractory Complex Partial Seizures Treated With Vigabatrin (Sabril®)

Search for Genes Influencing Childhood Absence Epilepsy (CAE) Study

Evaluation of the Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Women With Epilepsy: Pregnancy Outcomes and Deliveries

Lamotrigine Extended-Release In Elderly Patients With Epilepsy

Evaluation of the Pharmacokinetics, Safety, and Tolerability of TPM XR as Adjunctive Therapy in Pediatric Subjects With Epilepsy

Pediatric Epilepsy Study in Subjects 1-24 Months

Lethargic Depression Study

Does Memantine Improve Verbal Memory Task Performance in Subjects With Partial Epilepsy and Memory Dysfunction?

Retigabine Efficacy and Safety Trial for Partial Onset Refractory Seizures in Epilepsy

Other Conditions in New York